NOVYRA PHARMACHEM LIMITED Share Price

NOVYRA PHARMACHEM LIMITED Share Price

BSE: 519353
|
Tea/Coffee

₹ 8.50

+0.00 (0.00%)
1D
Last updated 13 Oct, 2026, 11:20 IST
--
0.00% up today
--
1D LOW
1D HIGH

NOVYRA PHARMACHEM LIMITED Returns Calculator

Volume
--
Average traded price
--
Last traded time
11:20:18 13 Oct
Last traded quantity
100
Circuit
L
H
₹8.08
₹8.92
52-week
L
H
₹6.79
₹16.55
Mkt Cap Cr
5.51
P/E
-1.03
P/B
8.86
ROA
-368.49%
ROE
-907.58%
ROCE
-907.58%
Quick Ratio
0.86
EV/EBITDA
-1.0
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
NOVYRA PHARMACHEM has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
NOVYRA PHARMACHEM appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
CCL Products14,035.7932.415.9810.0%16.55%16.07%0.7919.5
Pix Transmissions2,386.2018.113.4315.88%15.34%20.41%5.611.42
TINNA RUBBER AND INFR LTD1,589.2625.775.2911.66%17.59%19.28%0.6615.89
GRP920.80162.425.161.23%2.12%6.28%0.9324.25
International Conveyors509.293.741.223.94%16.11%19.4%4.653.0
McLeod Russel India475.27-5.09-1.08-3.97%-43.86%-4.42%0.14-13.34
RUBFILA INTERNATIONAL LTD335.5412.811.046.75%8.13%11.39%3.986.34
Harrison Malayalam314.1911.451.745.4%16.31%14.42%0.249.11
THE P K TEA PROD CO LTD267.8918.720.532.51%0.45%1.48%1.058.99
Elgi Rubber Co.271.99-1.353.54-45.59%-113.56%-13.93%0.5-3.79

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

About NOVYRA PHARMACHEM LIMITED

NOVYRA PHARMACHEM LIMITED Share Price
ISIN
INE856E01019
Sector Market Cap
₹ 5.51 Cr

Bansisons Tea Industries Limited is an India-based company. The Company is engaged in tea plantation, production and marketing.

NOVYRA PHARMACHEM LIMITED Financial Highlights

  • Revenue: NOVYRA PHARMACHEM LIMITED reported revenue of ₹0.16 crore in FY26 vs ₹0.05 crore in FY25. It showed an increase of 220.00% on a yearly basis.
  • Operating Profit: NOVYRA PHARMACHEM LIMITED reported an operating loss of ₹5.37 crore in FY26 vs ₹0.06 crore in FY25. It showed a decrease of 8,850.00% on a year-on-year basis.
  • Net Profit: NOVYRA PHARMACHEM LIMITED reported a net loss of ₹5.37 crore in FY26 vs ₹0.06 crore in FY25. It showed a decrease of 8,850.00% on a yearly basis.

NOVYRA PHARMACHEM LIMITED Quarterly Result Highlights

  • NOVYRA PHARMACHEM LIMITED reported revenue of ₹1.73 crore in Jun 2026, compared with ₹0.10 crore in Mar 2026, representing an increase of 1,630.00% on a quarter-on-quarter (QoQ) basis.
  • NOVYRA PHARMACHEM LIMITED reported an operating loss of ₹0.02 crore in Jun 2026, compared with ₹5.34 crore in Mar 2026, representing an increase of 99.63% on a quarter-on-quarter (QoQ) basis.
  • NOVYRA PHARMACHEM LIMITED reported a loss of ₹0.02 crore in Jun 2026, compared with ₹5.34 crore in Mar 2026, reflecting an increase of 99.63% on a QoQ basis.
  • The earnings per share (EPS) of NOVYRA PHARMACHEM LIMITED stood at ₹8.49 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
23.15%
FII
0.00%
Other DII
0.00%
Retail and other
76.85%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.00%
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
1 day
--
1 week
--
1 month
--
1 year
--
3 years
--
5 years
--
Day
Open / Close
Change %
13 Oct 26
₹8.50 / ₹8.50
-2.41%
29 Sep 26
₹8.71 / ₹8.71
-4.91%
22 Sep 26
₹9.16 / ₹9.16
-4.98%
18 Sep 26
₹10.14 / ₹9.64
-4.93%
Show more

NOVYRA PHARMACHEM LIMITED Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹0.10₹0.00₹0.00₹0.15
Other Income₹0.06₹0.05₹0.00₹0.01
Total Revenue₹0.17₹0.05₹0.00₹0.16
Total Expenses₹5.54₹0.11₹0.16₹0.12
Profit Before Tax-₹5.37-₹0.06-₹0.16₹0.03
Tax₹0.00₹0.00₹0.00₹0.02
Profit After Tax-₹5.37-₹0.06-₹0.16₹0.01
EPS - Basic-₹8.49-₹0.10-₹0.26₹0.02
EPS - Diluted-₹8.49-₹0.10-₹0.26₹0.02

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax-₹5.37-₹0.06-₹0.16₹0.03
Income before WC changes-₹5.41-₹0.08-₹0.14₹0.05
Change in Assets₹0.78₹0.06-₹0.03₹0.10
Change in Liabilities₹0.84-₹0.27₹0.04₹0.02
Change in WC₹1.62-₹0.21₹0.00₹0.11
Cash flow from Operations-₹3.79-₹0.28-₹0.14₹0.14
Cash flow from Investing₹3.85₹0.08₹0.00₹0.01
Cash flow from Financing-₹0.15₹0.28₹0.00₹0.00
Total Cash Flow-₹0.09₹0.08-₹0.14₹0.14
Cash (Start of the year)₹0.26₹0.09₹0.22₹0.08
Cash (End of the year)₹0.18₹0.26₹0.09₹0.22

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹0.74₹5.85₹5.89₹5.87
Current Assets₹0.75₹0.30₹0.23₹0.37
Total Assets₹1.49₹6.14₹6.12₹6.24
Current Liabilities₹0.87₹0.18₹0.09₹0.06
Net Current Asset-₹0.12₹0.12₹0.14₹0.31
Non-Current Liabilities₹0.00₹0.00₹0.10₹0.10
Equity Capital₹0.62₹5.97₹5.93₹6.09
Total Equity & Liabilities₹1.49₹6.14₹6.12₹6.24
* All values are in INR Crore
Qty
Bid
900
8.08
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 900
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
3
Neutral
1
Bullish
4
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
11.53
Bearish
ATR (14)
0.27
Neutral
STOCH(9,6)
0
Bullish
STOCH RSI (14)
20.94
Bullish
ADX(9)
60.07
Bearish
UO(9)
6.74
Bullish
ROC(12)
-20.56
Bearish
WillR(14)
-100
Bullish
Period
Simple value
Exponential vaue
5D
9.66
9.47
10D
10.07
9.98
20D
10.71
10.81
50D
13.14
11.17
100D
12.1
0
Volume trend — traded volume by day
13 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
NOVYRA PHARMACHEM LIMITED Share Price
NOVYRA PHARMACHEM LIMITED
Tea/Coffee
Add Stock
Add Another

NOVYRA PHARMACHEM LIMITED Share Price FAQs

Disclaimer: The information on this page, including prices, charts, financials, ratios, and other data, is provided for informational and educational purposes only. It is not investment advice, a research report, or a recommendation or solicitation to buy, sell, or hold any security. Data is sourced from third parties and exchanges, may be delayed, and is not guaranteed to be accurate, complete, or timely. Upstox is not liable for any loss arising from its use.